{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T23:19:47Z","timestamp":1785021587798,"version":"3.55.0"},"reference-count":260,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s40263-021-00820-1","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T14:02:51Z","timestamp":1621087371000},"page":"483-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5878-3859","authenticated-orcid":false,"given":"Colin J.","family":"Mahoney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicong","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Rohrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Bedlack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orla","family":"Hardiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9054-026X","authenticated-orcid":false,"given":"Matthew C.","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,15]]},"reference":[{"key":"820_CR1","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942\u201355.","journal-title":"Lancet"},{"key":"820_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/jnnp-2016-314495","volume":"88","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Brayne C, Beghi E, van den Berg LH, Chio A, et al. The changing picture of amyotrophic lateral sclerosis: lessons from European registers. J Neurol Neurosurg Psychiatry. 2017;88:557\u201363.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S1474-4422(15)00380-4","volume":"15","author":"RM Ahmed","year":"2016","unstructured":"Ahmed RM, Irish M, Piguet O, Halliday GM, Ittner LM, Farooqi S, et al. Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism. Lancet Neurol. 2016;15:332\u201342.","journal-title":"Lancet Neurol."},{"key":"820_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/WCO.0000000000000488","volume":"30","author":"MJ Strong","year":"2017","unstructured":"Strong MJ. Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expression. Curr Opin Neurol. 2017;30:599\u2013607.","journal-title":"Curr Opin Neurol."},{"key":"820_CR5","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.neuron.2012.03.004","volume":"73","author":"J Zhou","year":"2012","unstructured":"Zhou J, Gennatas ED, Kramer JH, Miller BL, Seeley WW. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron. 2012;73:1216\u201327.","journal-title":"Neuron"},{"key":"820_CR6","doi-asserted-by":"publisher","first-page":"12408","DOI":"10.1038\/ncomms12408","volume":"7","author":"KC Arthur","year":"2016","unstructured":"Arthur KC, Calvo A, Price TR, Geiger JT, Chi\u00f2 A, Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7:12408.","journal-title":"Nat Commun."},{"key":"820_CR7","first-page":"433","volume":"21","author":"A Cullerre","year":"1906","unstructured":"Cullerre A. Troubles mentales dans la scl\u00e9rose lat\u00e9: rale amyotrophique. Arch Neurol. 1906;21:433\u201350.","journal-title":"Arch Neurol."},{"key":"820_CR8","first-page":"642","volume":"84","author":"A Hirano","year":"1961","unstructured":"Hirano A, Kurland LT, Krooth RS, Lessell S. Parkinsonism-dementia complex, an endemic disease on the island of Guam. I Clinical features Brain J Neurol. 1961;84:642\u201361.","journal-title":"I. Clinical features. Brain J Neurol."},{"key":"820_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/brain\/104.2.217","volume":"104","author":"AJ Hudson","year":"1981","unstructured":"Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain J Neurol. 1981;104:217\u201347.","journal-title":"Brain J Neurol."},{"key":"820_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/jnnp.53.1.23","volume":"53","author":"D Neary","year":"1990","unstructured":"Neary D, Snowden JS, Mann DM, Northen B, Goulding PJ, Macdermott N. Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry. 1990;53:23\u201332.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"2","key":"820_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A, Sim\u00f3n-S\u00e1nchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257\u201368.","journal-title":"Neuron"},{"key":"820_CR12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12031-010-9467-1","volume":"43","author":"M Dadon-Nachum","year":"2011","unstructured":"Dadon-Nachum M, Melamed E, Offen D. The, \u201cdying-back\u201d phenomenon of motor neurons in ALS. J Mol Neurosci. 2011;43:470\u20137.","journal-title":"J Mol Neurosci."},{"key":"820_CR13","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1093\/brain\/awr195","volume":"134","author":"JR Burrell","year":"2011","unstructured":"Burrell JR, Kiernan MC, Vucic S, Hodges JR. Motor neuron dysfunction in frontotemporal dementia. Brain. 2011;134:2582\u201394.","journal-title":"Brain"},{"key":"820_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/alzrt144","volume":"4","author":"CJ Mahoney","year":"2012","unstructured":"Mahoney CJ, Downey LE, Ridgway GR, Beck J, Clegg S, Blair M, et al. Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions. Alzheimers Res Ther. 2012;4:41.","journal-title":"Alzheimers Res Ther."},{"key":"820_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41583-019-0177-6","volume":"20","author":"MP van den Heuvel","year":"2019","unstructured":"van den Heuvel MP, Sporns O. A cross-disorder connectome landscape of brain dysconnectivity. Nat Rev Neurosci. 2019;20:435\u201346.","journal-title":"Nat Rev Neurosci."},{"key":"820_CR16","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/hbm.22258","volume":"35","author":"E Verstraete","year":"2014","unstructured":"Verstraete E, Veldink JH, van den Berg LH, van den Heuvel MP. Structural brain network imaging shows expanding disconnection of the motor system in amyotrophic lateral sclerosis. Hum Brain Mapp. 2014;35:1351\u201361.","journal-title":"Hum Brain Mapp."},{"key":"820_CR17","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1136\/jnnp-2018-318625","volume":"89","author":"S Tu","year":"2018","unstructured":"Tu S, Menke RAL, Talbot K, Kiernan MC, Turner MR. Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2018;89:1250\u20138.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR18","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/ana.24801","volume":"80","author":"MR Turner","year":"2016","unstructured":"Turner MR, Goldacre R, Talbot K, Goldacre MJ. Psychiatric disorders prior to amyotrophic lateral sclerosis. Ann Neurol. 2016;80:935\u20138.","journal-title":"Ann Neurol."},{"key":"820_CR19","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1212\/WNL.0000000000004179","volume":"89","author":"E Longinetti","year":"2017","unstructured":"Longinetti E, Mariosa D, Larsson H, Ye W, Ingre C, Almqvist C, et al. Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis. Neurology. 2017;89:578\u201385.","journal-title":"Neurology"},{"key":"820_CR20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ana.23969","volume":"74","author":"S Byrne","year":"2013","unstructured":"Byrne S, Heverin M, Elamin M, Bede P, Lynch C, Kenna K, et al. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis. Ann Neurol. 2013;74:699\u2013708.","journal-title":"Ann Neurol."},{"issue":"16","key":"820_CR21","doi-asserted-by":"publisher","first-page":"e1498","DOI":"10.1212\/WNL.0000000000006344","volume":"91","author":"EM Devenney","year":"2018","unstructured":"Devenney EM, Ahmed RM, Halliday G, Piguet O, Kiernan MC, Hodges JR. Psychiatric disorders in C9orf72 kindreds: study of 1,414 family members. Neurology. 2018;91(16):e1498\u2013507.","journal-title":"Neurology"},{"key":"820_CR22","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/jamaneurol.2017.2699","volume":"74","author":"M O\u2019Brien","year":"2017","unstructured":"O\u2019Brien M, Burke T, Heverin M, Vajda A, McLaughlin R, Gibbons J, et al. Clustering of neuropsychiatric disease in first-degree and second-degree relatives of patients with amyotrophic lateral sclerosis. JAMA Neurol. 2017;74:1425.","journal-title":"JAMA Neurol."},{"key":"820_CR23","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10654-017-0318-z","volume":"32","author":"RS Peter","year":"2017","unstructured":"Peter RS, Rosenbohm A, Dupuis L, Brehme T, Kassubek J, Rothenbacher D, et al. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Eur J Epidemiol. 2017;32:901\u20138.","journal-title":"Eur J Epidemiol."},{"key":"820_CR24","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/ana.24936","volume":"81","author":"D Mariosa","year":"2017","unstructured":"Mariosa D, Hammar N, Malmstr\u00f6m H, Ingre C, Jungner I, Ye W, et al. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort. Ann Neurol. 2017;81:718\u201328.","journal-title":"Ann Neurol."},{"key":"820_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/jamaneurol.2017.4266","volume":"75","author":"A Bertrand","year":"2018","unstructured":"Bertrand A, Wen J, Rinaldi D, Houot M, Sayah S, Camuzat A, et al. Early cognitive, structural, and microstructural changes in presymptomatic C9orf72 carriers younger than 40 years. JAMA Neurol. 2018;75:236.","journal-title":"JAMA Neurol."},{"key":"820_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.nicl.2016.12.006","volume":"14","author":"SE Lee","year":"2017","unstructured":"Lee SE, Sias AC, Mandelli ML, Brown JA, Brown AB, Khazenzon AM, et al. Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers. NeuroImage Clin. 2017;14:286\u201397.","journal-title":"NeuroImage Clin."},{"key":"820_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1474-4422(14)70324-2","volume":"14","author":"JD Rohrer","year":"2015","unstructured":"Rohrer JD, Nicholas JM, Cash DM, van Swieten J, Dopper E, Jiskoot L, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. 2015;14:253\u201362.","journal-title":"Lancet Neurol."},{"key":"820_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2018.12.017","volume":"76","author":"JL Panman","year":"2019","unstructured":"Panman JL, Jiskoot LC, Bouts MJRJ, Meeter LHH, van der Ende EL, Poos JM, et al. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study. Neurobiol Aging. 2019;76:115\u201324.","journal-title":"Neurobiol Aging."},{"key":"820_CR29","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1212\/WNL.0000000000004393","volume":"89","author":"JM Papma","year":"2017","unstructured":"Papma JM, Jiskoot LC, Panman JL, Dopper EG, den Heijer T, Donker Kaat L, et al. Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion. Neurology. 2017;89:1256\u201364.","journal-title":"Neurology"},{"key":"820_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neurobiolaging.2018.12.009","volume":"77","author":"T Rittman","year":"2019","unstructured":"Rittman T, Borchert R, Jones S, van Swieten J, Borroni B, Galimberti D, et al. Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia. Neurobiol Aging. 2019;77:169\u201377.","journal-title":"Neurobiol Aging."},{"key":"820_CR31","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/archneurol.2010.146","volume":"67","author":"P Lillo","year":"2010","unstructured":"Lillo P, Garcin B, Hornberger M, Bak TH, Hodges JR. Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol. 2010;67:826\u201330.","journal-title":"Arch Neurol."},{"key":"820_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1212\/WNL.0000000000000023","volume":"82","author":"E Mioshi","year":"2014","unstructured":"Mioshi E, Caga J, Lillo P, Hsieh S, Ramsey E, Devenney E, et al. Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival. Neurology. 2014;82:149\u201355.","journal-title":"Neurology"},{"key":"820_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1468-1331.2009.02801.x","volume":"17","author":"M Witgert","year":"2010","unstructured":"Witgert M, Salamone AR, Strutt AM, Jawaid A, Massman PJ, Bradshaw M, et al. Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. Eur J Neurol. 2010;17:103\u201310.","journal-title":"Eur J Neurol."},{"key":"820_CR34","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3109\/17482968.2010.516265","volume":"11","author":"Z Chen","year":"2010","unstructured":"Chen Z, Ma L. Grey matter volume changes over the whole brain in amyotrophic lateral sclerosis: A voxel-wise meta-analysis of voxel based morphometry studies. Amyotroph Lateral Scler. 2010;11:549\u201354.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR35","doi-asserted-by":"publisher","first-page":"15389","DOI":"10.1038\/s41598-018-33830-z","volume":"8","author":"M Gorges","year":"2018","unstructured":"Gorges M, Del Tredici K, Dreyhaupt J, Braak H, Ludolph AC, M\u00fcller H-P, et al. Corticoefferent pathology distribution in amyotrophic lateral sclerosis: in vivo evidence from a meta-analysis of diffusion tensor imaging data. Sci Rep. 2018;8:15389.","journal-title":"Sci Rep."},{"key":"820_CR36","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S1474-4422(14)70167-X","volume":"13","author":"A Chi\u00f2","year":"2014","unstructured":"Chi\u00f2 A, Pagani M, Agosta F, Calvo A, Cistaro A, Filippi M. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. Lancet Neurol. 2014;13:1228\u201340.","journal-title":"Lancet Neurol."},{"key":"820_CR37","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1016\/j.neurobiolaging.2015.08.018","volume":"36","author":"L Sheng","year":"2015","unstructured":"Sheng L, Ma H, Zhong J, Shang H, Shi H, Pan P. Motor and extra-motor gray matter atrophy in amyotrophic lateral sclerosis: quantitative meta-analyses of voxel-based morphometry studies. Neurobiol Aging. 2015;36:3288\u201399.","journal-title":"Neurobiol Aging."},{"key":"820_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.nicl.2018.04.005","volume":"19","author":"F Zhang","year":"2018","unstructured":"Zhang F, Chen G, He M, Dai J, Shang H, Gong Q, et al. Altered white matter microarchitecture in amyotrophic lateral sclerosis: a voxel-based meta-analysis of diffusion tensor imaging. NeuroImage Clin. 2018;19:122\u20139.","journal-title":"NeuroImage Clin."},{"key":"820_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1212\/WNL.0b013e31829c5eee","volume":"81","author":"P Bede","year":"2013","unstructured":"Bede P, Bokde ALW, Byrne S, Elamin M, McLaughlin RL, Kenna K, et al. Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology. 2013;81:361\u20139.","journal-title":"Neurology"},{"key":"820_CR40","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/brain\/awr361","volume":"135","author":"CJ Mahoney","year":"2012","unstructured":"Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain J Neurol. 2012;135:736\u201350.","journal-title":"Brain J Neurol."},{"key":"820_CR41","doi-asserted-by":"publisher","first-page":"e707","DOI":"10.1212\/WNL.0000000000005002","volume":"90","author":"F Agosta","year":"2018","unstructured":"Agosta F, Spinelli EG, Marjanovic IV, Stevic Z, Pagani E, Valsasina P, et al. Unraveling ALS due to SOD1 mutation through the combination of brain and cervical cord MRI. Neurology. 2018;90:e707\u201316.","journal-title":"Neurology"},{"key":"820_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1212\/WNL.0000000000002242","volume":"86","author":"A Canosa","year":"2016","unstructured":"Canosa A, Pagani M, Cistaro A, Montuschi A, Iazzolino B, Fania P, et al. 18F-FDG-PET correlates of cognitive impairment in ALS. Neurology. 2016;86:44\u20139.","journal-title":"Neurology"},{"key":"820_CR43","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1212\/WNL.0000000000000792","volume":"83","author":"M Pagani","year":"2014","unstructured":"Pagani M, Chio A, Valentini MC, Oberg J, Nobili F, Calvo A, et al. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis. Neurology. 2014;83:1067\u201374.","journal-title":"Neurology"},{"key":"820_CR44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jamaneurol.2014.62","volume":"71","author":"K Van Laere","year":"2014","unstructured":"Van Laere K, Vanhee A, Verschueren J, De Coster L, Driesen A, Dupont P, et al. Value of 18Fluorodeoxyglucose\u2013positron-emission tomography in amyotrophic lateral sclerosis: a prospective study. JAMA Neurol. 2014;71:553.","journal-title":"JAMA Neurol."},{"key":"820_CR45","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3389\/fneur.2018.01148","volume":"9","author":"M Proudfoot","year":"2019","unstructured":"Proudfoot M, Bede P, Turner MR. Imaging cerebral activity in amyotrophic lateral sclerosis. Front Neurol. 2019;9:1148.","journal-title":"Front Neurol."},{"issue":"10","key":"820_CR46","first-page":"204","volume":"10","author":"C Zhou","year":"2016","unstructured":"Zhou C, Hu X, Hu J, Liang M, Yin X, Chen L, et al. Altered brain network in amyotrophic lateral sclerosis: a resting graph theory-based network study at voxel-wise level. Front Neurosci. 2016;10(10):204.","journal-title":"Front Neurosci."},{"key":"820_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cortex.2017.09.016","volume":"97","author":"F Trojsi","year":"2017","unstructured":"Trojsi F, Di Nardo F, Santangelo G, Siciliano M, Femiano C, Passaniti C, et al. Resting state fMRI correlates of theory of mind impairment in amyotrophic lateral sclerosis. Cortex. 2017;97:1\u201316.","journal-title":"Cortex"},{"key":"820_CR48","doi-asserted-by":"publisher","first-page":"e85190","DOI":"10.1371\/journal.pone.0085190","volume":"8","author":"T Fekete","year":"2013","unstructured":"Fekete T, Zach N, Mujica-Parodi LR, Turner MR. Multiple kernel learning captures a systems-level Functional connectivity biomarker signature in amyotrophic lateral sclerosis. PLoS ONE. 2013;8:e85190.","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"820_CR49","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/ana.21543","volume":"65","author":"JD Rothstein","year":"2009","unstructured":"Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009;65(Suppl 1):S3-9.","journal-title":"Ann Neurol."},{"key":"820_CR50","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/jnnp-2018-318795","volume":"90","author":"I Cheong","year":"2019","unstructured":"Cheong I, Deelchand DK, Eberly LE, Marja\u0144ska M, Manousakis G, Guliani G, et al. Neurochemical correlates of functional decline in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90:294\u2013301.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR51","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1093\/brain\/123.11.2289","volume":"123","author":"CM Lloyd","year":"2000","unstructured":"Lloyd CM, Richardson MP, Brooks DJ, Al-Chalabi A, Leigh PN. Extramotor involvement in ALS: PET studies with the GABAA ligand [11C]flumazenil. Brain. 2000;123:2289\u201396.","journal-title":"Brain"},{"key":"820_CR52","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jns.2017.03.013","volume":"377","author":"X Fu","year":"2017","unstructured":"Fu X, Zhu W, Guo Z, Shu G, Cui F, Yang F, et al. 18 F-fallypride PET-CT of dopamine D2\/D3 receptors in patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci. 2017;377:79\u201384.","journal-title":"J Neurol Sci."},{"key":"820_CR53","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1212\/WNL.52.6.1275","volume":"52","author":"OJ Vogels","year":"1999","unstructured":"Vogels OJ, Oyen WJ, van Engelen BG, Padberg GW, Horstink MW. Decreased striatal dopamine-receptor binding in sporadic ALS: glutamate hyperactivity? Neurology. 1999;52:1275\u20137.","journal-title":"Neurology"},{"key":"820_CR54","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/brain\/awh428","volume":"128","author":"MR Turner","year":"2005","unstructured":"Turner MR. [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. Brain. 2005;128:896\u2013905.","journal-title":"Brain"},{"key":"820_CR55","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/0022-510X(94)90175-9","volume":"124","author":"J Lowe","year":"1994","unstructured":"Lowe J. New pathological findings in amyotrophic lateral sclerosis. J Neurol Sci. 1994;124:38\u201351.","journal-title":"J Neurol Sci."},{"key":"820_CR56","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1440-1789.1993.tb00200.x","volume":"13","author":"I Nakano","year":"1993","unstructured":"Nakano I. Temporal lobe lesions in amyotrophic lateral sclerosis with or without dementia: a neuropathological study. Neuropathology. 1993;13:215\u201327.","journal-title":"Neuropathology"},{"issue":"5","key":"820_CR57","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/archneur.65.5.636","volume":"65","author":"F Geser","year":"2008","unstructured":"Geser F, Brandmeir NJ, Kwong LK, Martinez-Lage M, Elman L, McCluskey L, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol. 2008;65(5):636\u201341.","journal-title":"Arch Neurol."},{"issue":"4","key":"820_CR58","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/neup.12105","volume":"34","author":"T Kimura","year":"2014","unstructured":"Kimura T, Jiang H, Konno T, Seto M, Iwanaga K, Tsujihata M, et al. Bunina bodies in motor and non-motor neurons revisited: a pathological study of an ALS patient after long-term survival on a respirator. Neuropathology. 2014;34(4):392\u20137.","journal-title":"Neuropathology"},{"key":"820_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1750-3639.2003.tb00002.x","volume":"13","author":"Y-S Piao","year":"2003","unstructured":"Piao Y-S, Wakabayashi K, Kakita A, Yamada M, Hayashi S, Morita T, et al. Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol. 2003;13:10\u201322.","journal-title":"Brain Pathol."},{"key":"820_CR60","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","volume":"15","author":"MR Turner","year":"2004","unstructured":"Turner MR, Cagnin A, Turkheimer FE, Miller CCJ, Shaw CE, Brooks DJ, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis. 2004;15:601\u20139.","journal-title":"Neurobiol Dis."},{"key":"820_CR61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnins.2019.00175","volume":"13","author":"E Zucchi","year":"2019","unstructured":"Zucchi E, Ticozzi N, Mandrioli J. Psychiatric symptoms in amyotrophic lateral sclerosis: beyond a motor neuron disorder. Front Neurosci. 2019;13:175.","journal-title":"Front Neurosci."},{"key":"820_CR62","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/17482968.2010.536839","volume":"12","author":"N Atassi","year":"2011","unstructured":"Atassi N, Cook A, Pineda CME, Yerramilli-Rao P, Pulley D, Cudkowicz M. Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:109\u201312.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR63","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3109\/17482960802459889","volume":"10","author":"JG Rabkin","year":"2009","unstructured":"Rabkin JG, Albert SM, Rowland LP, Mitsumoto H. How common is depression among ALS caregivers? A longitudinal study. Amyotroph Lateral Scler. 2009;10:448\u201355.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR64","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1212\/WNL.0000000000002465","volume":"86","author":"NJ Thakore","year":"2016","unstructured":"Thakore NJ, Pioro EP. Depression in ALS in a large self-reporting cohort. Neurology. 2016;86:1031\u20138.","journal-title":"Neurology"},{"key":"820_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/2237-6089-2015-0030","volume":"38","author":"TL Carvalho","year":"2016","unstructured":"Carvalho TL, de Almeida LMS, Lorega CMA, Barata MFO, Ferreira MLB, de Brito-Marques PR, et al. Depression and anxiety in individuals with amyotrophic lateral sclerosis: a systematic review. Trends Psychiatry Psychother. 2016;38:1\u20135.","journal-title":"Trends Psychiatry Psychother."},{"key":"820_CR66","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/j.1468-1331.2008.02303.x","volume":"15","author":"A Vignola","year":"2008","unstructured":"Vignola A, Guzzo A, Calvo A, Moglia C, Pessia A, Cavallo E, et al. Anxiety undermines quality of life in ALS patients and caregivers. Eur J Neurol. 2008;15:1231\u20136.","journal-title":"Eur J Neurol."},{"issue":"1","key":"820_CR67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/mus.26475","volume":"60","author":"M Siciliano","year":"2019","unstructured":"Siciliano M, Trojano L, Trojsi F, Monsurr\u00f2 MR, Tedeschi G, Santangelo G. Assessing anxiety and its correlates in amyotrophic lateral sclerosis: the state-trait anxiety inventory. Muscle Nerve. 2019;60(1):47\u201355.","journal-title":"Muscle Nerve."},{"key":"820_CR68","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2165\/00023210-200721040-00003","volume":"21","author":"A Kurt","year":"2007","unstructured":"Kurt A, Nijboer F, Matuz T, K\u00fcbler A. Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs. 2007;21:279\u201391.","journal-title":"CNS Drugs"},{"key":"820_CR69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1212\/01.wnl.0000168161.54833.bb","volume":"65","author":"SM Albert","year":"2005","unstructured":"Albert SM, Rabkin JG, Del Bene ML, Tider T, O\u2019Sullivan I, Rowland LP, et al. Wish to die in end-stage ALS. Neurology. 2005;65:68\u201374.","journal-title":"Neurology"},{"key":"820_CR70","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/brain\/awn161","volume":"131","author":"F Fang","year":"2008","unstructured":"Fang F, Valdimarsd\u00f3ttir U, F\u00fcrst CJ, Hultman C, Fall K, Spar\u00e9n P, et al. Suicide among patients with amyotrophic lateral sclerosis. Brain. 2008;131:2729\u201333.","journal-title":"Brain"},{"key":"820_CR71","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/21678421.2013.765485","volume":"14","author":"JS Snowden","year":"2013","unstructured":"Snowden JS, Harris J, Richardson A, Rollinson S, Thompson JC, Neary D, et al. Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72. Amyotroph Lateral Scler Front Degener. 2013;14:172\u20136.","journal-title":"Amyotroph Lateral Scler Front Degener."},{"key":"820_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2018.10.010","volume":"145","author":"C Mor\u00e9lot-Panzini","year":"2018","unstructured":"Mor\u00e9lot-Panzini C, Perez T, Sedkaoui K, de Bock E, Aguilaniu B, Devillier P, et al. The multidimensional nature of dyspnoea in amyotrophic lateral sclerosis patients with chronic respiratory failure: air hunger, anxiety and fear. Respir Med. 2018;145:1\u20137.","journal-title":"Respir Med."},{"key":"820_CR73","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/brain\/awf149","volume":"125","author":"PJ Harrison","year":"2002","unstructured":"Harrison PJ. The neuropathology of primary mood disorder. Brain. 2002;125:1428\u201349.","journal-title":"Brain"},{"key":"820_CR74","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.nicl.2013.08.016","volume":"3","author":"SM Grieve","year":"2013","unstructured":"Grieve SM, Korgaonkar MS, Koslow SH, Gordon E, Williams LM. Widespread reductions in gray matter volume in depression. NeuroImage Clin. 2013;3:332\u20139.","journal-title":"NeuroImage Clin."},{"key":"820_CR75","doi-asserted-by":"publisher","first-page":"14774","DOI":"10.1038\/ncomms14774","volume":"8","author":"RL McLaughlin","year":"2017","unstructured":"McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O\u2019Brien M, Kahn RS, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nat Commun. 2017;8:14774.","journal-title":"Nat Commun."},{"key":"820_CR76","doi-asserted-by":"publisher","first-page":"e1370","DOI":"10.1212\/WNL.0000000000006317","volume":"91","author":"C Crockford","year":"2018","unstructured":"Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology. 2018;91:e1370\u201380.","journal-title":"Neurology"},{"key":"820_CR77","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/jnnp-2011-300188","volume":"83","author":"J Phukan","year":"2012","unstructured":"Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83:102\u20138.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR78","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1212\/WNL.0000000000008063","volume":"93","author":"A Chi\u00f2","year":"2019","unstructured":"Chi\u00f2 A, Moglia C, Canosa A, Manera U, Vasta R, Brunetti M, et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology. 2019;93:e984\u201394.","journal-title":"Neurology"},{"key":"820_CR79","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/jnnp-2015-310734","volume":"87","author":"E Beeldman","year":"2016","unstructured":"Beeldman E, Raaphorst J, Twennaar MK, de Visser M, Schmand BA, de Haan RJ. The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry. 2016;87:611\u20139.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR80","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1212\/01.WNL.0000156519.41681.27","volume":"64","author":"S Abrahams","year":"2005","unstructured":"Abrahams S, Leigh PN, Goldstein LH. Cognitive change in ALS: a prospective study. Neurology. 2005;64:1222\u20136.","journal-title":"Neurology"},{"key":"820_CR81","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1212\/01.wnl.0000172911.39167.b6","volume":"65","author":"GM Ringholz","year":"2005","unstructured":"Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586\u201390.","journal-title":"Neurology"},{"key":"820_CR82","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S0028-3932(99)00146-3","volume":"38","author":"S Abrahams","year":"2000","unstructured":"Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Gris\u00e9 D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000;38:734\u201347.","journal-title":"Neuropsychologia"},{"key":"820_CR83","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1093\/brain\/awq254","volume":"133","author":"SL Meier","year":"2010","unstructured":"Meier SL, Charleston AJ, Tippett LJ. Cognitive and behavioural deficits associated with the orbitomedial prefrontal cortex in amyotrophic lateral sclerosis. Brain. 2010;133:3444\u201357.","journal-title":"Brain"},{"key":"820_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cortex.2016.11.012","volume":"88","author":"E Bora","year":"2017","unstructured":"Bora E. Meta-analysis of social cognition in amyotrophic lateral sclerosis. Cortex. 2017;88:1\u20137.","journal-title":"Cortex"},{"key":"820_CR85","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1037\/a0020357","volume":"25","author":"A Girardi","year":"2011","unstructured":"Girardi A, MacPherson SE, Abrahams S. Deficits in emotional and social cognition in amyotrophic lateral sclerosis. Neuropsychology. 2011;25:53\u201365.","journal-title":"Neuropsychology"},{"key":"820_CR86","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fnhum.2013.00178","volume":"7","author":"M Staios","year":"2013","unstructured":"Staios M, Fisher F, Lindell A, Ong B, Howe J, Reardon K. Exploring sarcasm detection in amyotrophic lateral sclerosis using ecologically valid measures. Front Hum Neurosci. 2013;7:178.","journal-title":"Front Hum Neurosci."},{"key":"820_CR87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3109\/21678421.2014.987301","volume":"16","author":"FVC Leslie","year":"2015","unstructured":"Leslie FVC, Hsieh S, Caga J, Savage SA, Mioshi E, Hornberger M, et al. Semantic deficits in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2015;16:46\u201353.","journal-title":"Amyotroph Lateral Scler Front Degener."},{"key":"820_CR88","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/jnnp-2012-303526","volume":"84","author":"LJ Taylor","year":"2013","unstructured":"Taylor LJ, Brown RG, Tsermentseli S, Al-Chalabi A, Shaw CE, Ellis CM, et al. Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry. 2013;84:494\u20138.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR89","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/21678421.2016.1272615","volume":"18","author":"T Burke","year":"2017","unstructured":"Burke T, Lonergan K, Pinto-Grau M, Elamin M, Bede P, Madden C, et al. Visual encoding, consolidation, and retrieval in amyotrophic lateral sclerosis: executive function as a mediator, and predictor of performance. Amyotroph Lateral Scler Front Degener. 2017;18:193\u2013201.","journal-title":"Amyotroph Lateral Scler Front Degener."},{"key":"820_CR90","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.neurobiolaging.2013.07.020","volume":"35","author":"C Schuster","year":"2014","unstructured":"Schuster C, Kasper E, Dyrba M, Machts J, Bittner D, Kaufmann J, et al. Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35:240\u20136.","journal-title":"Neurobiol Aging."},{"key":"820_CR91","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/21678421.2014.974617","volume":"16","author":"S Ash","year":"2015","unstructured":"Ash S, Olm C, McMillan CT, Boller A, Irwin DJ, McCluskey L, et al. Deficits in sentence expression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2015;16:31\u20139.","journal-title":"Amyotroph Lateral Scler Front Degener."},{"key":"820_CR92","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11065-018-9375-7","volume":"28","author":"M Pinto-Grau","year":"2018","unstructured":"Pinto-Grau M, Hardiman O, Pender N. The study of language in the amyotrophic lateral sclerosis: frontotemporal spectrum disorder: a systematic review of findings and new perspectives. Neuropsychol Rev. 2018;28:251\u201368.","journal-title":"Neuropsychol Rev."},{"key":"820_CR93","doi-asserted-by":"publisher","first-page":"105710","DOI":"10.1016\/j.bandc.2021.105710","volume":"150","author":"C Nguyen","year":"2021","unstructured":"Nguyen C, Caga J, Mahoney CJ, Kiernan MC, Huynh W. Behavioural changes predict poorer survival in amyotrophic lateral sclerosis. Brain Cogn. 2021;150:105710.","journal-title":"Brain Cogn."},{"key":"820_CR94","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/jnen\/nlx104","volume":"77","author":"H Braak","year":"2018","unstructured":"Braak H, Del Tredici K. Anterior cingulate cortex TDP-43 pathology in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2018;77:74\u201383.","journal-title":"J Neuropathol Exp Neurol."},{"key":"820_CR95","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3109\/17482968.2012.656652","volume":"13","author":"J Raaphorst","year":"2012","unstructured":"Raaphorst J, Beeldman E, Visser MD, Haan RJD, Schmand B. A systematic review of behavioural changes in motor neuron disease. Amyotroph Lateral Scler. 2012;13:493\u2013501.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR96","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/jnnp-2018-318788","volume":"90","author":"BS de Vries","year":"2019","unstructured":"de Vries BS, Rustemeijer LMM, Bakker LA, Schr\u00f6der CD, Veldink JH, van den Berg LH, et al. Cognitive and behavioural changes in PLS and PMA: challenging the concept of restricted phenotypes. J Neurol Neurosurg Psychiatry. 2019;90:141\u20137.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR97","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1586\/ern.11.68","volume":"11","author":"A Miller","year":"2011","unstructured":"Miller A, Pratt H, Schiffer RB. Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments. Expert Rev Neurother. 2011;11:1077\u201388.","journal-title":"Expert Rev Neurother."},{"issue":"8","key":"820_CR98","doi-asserted-by":"publisher","first-page":"e72232","DOI":"10.1371\/journal.pone.0072232","volume":"8","author":"BR Brooks","year":"2013","unstructured":"Brooks BR, Crumpacker D, Fellus J, Kantor D, Kaye RE. PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions. PLoS ONE. 2013;8(8):e72232.","journal-title":"PLoS ONE"},{"key":"820_CR99","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/jnnp-2017-315622","volume":"88","author":"NJ Thakore","year":"2017","unstructured":"Thakore NJ, Pioro EP. Laughter, crying and sadness in ALS. J Neurol Neurosurg Psychiatry. 2017;88:825\u201331.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR100","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/acn3.407","volume":"4","author":"T Burke","year":"2017","unstructured":"Burke T, Pinto-Grau M, Lonergan K, Bede P, O\u2019Sullivan M, Heverin M, et al. A cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival. Ann Clin Transl Neurol. 2017;4:305\u201317.","journal-title":"Ann Clin Transl Neurol."},{"key":"820_CR101","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1468-1331.2010.02960.x","volume":"17","author":"L Taylor","year":"2010","unstructured":"Taylor L, Wicks P, Leigh PN, Goldstein LH. Prevalence of depression in amyotrophic lateral sclerosis and other motor disorders. Eur J Neurol. 2010;17:1047\u201353.","journal-title":"Eur J Neurol."},{"key":"820_CR102","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1176\/jnp.12.2.233","volume":"12","author":"DI Kaufer","year":"2000","unstructured":"Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12:233\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"820_CR103","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/21678421.2015.1030430","volume":"16","author":"E Niven","year":"2015","unstructured":"Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, et al. Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): a cognitive tool for motor disorders. Amyotroph Lateral Scler Front Degener. 2015;16:172\u20139.","journal-title":"Amyotroph Lateral Scler Front Degener."},{"key":"820_CR104","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3109\/17482961003727954","volume":"11","author":"SC Woolley","year":"2010","unstructured":"Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, et al. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBSTM). Amyotroph Lateral Scler. 2010;11:303\u201311.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR105","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/21678421.2018.1491601","volume":"19","author":"MM De Icaza Valenzuela","year":"2018","unstructured":"De Icaza Valenzuela MM, Bak TH, Pal S, Abrahams S. The Edinburgh cognitive and behavioral ALS screen: relationship to age, education, IQ and the Addenbrooke\u2019s Cognitive Examination-III. Amyotroph Lateral Scler Front Degener. 2018;19:585\u201390.","journal-title":"Amyotroph Lateral Scler Front Degener."},{"key":"820_CR106","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1136\/jnnp-2015-310772","volume":"87","author":"R Radakovic","year":"2016","unstructured":"Radakovic R, Stephenson L, Colville S, Swingler R, Chandran S, Abrahams S. Multidimensional apathy in ALS: validation of the Dimensional Apathy Scale. J Neurol Neurosurg Psychiatry. 2016;87:663\u20139.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR107","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/21678421.2016.1248976","volume":"18","author":"M Elamin","year":"2017","unstructured":"Elamin M, Pinto-Grau M, Burke T, Bede P, Rooney J, O\u2019Sullivan M, et al. Identifying behavioural changes in ALS: validation of the Beaumont Behavioural Inventory (BBI). Amyotroph Lateral Scler Front Degener. 2017;18:68\u201373.","journal-title":"Amyotroph Lateral Scler Front Degener."},{"key":"820_CR108","doi-asserted-by":"publisher","first-page":"e0200953","DOI":"10.1371\/journal.pone.0200953","volume":"13","author":"B Poletti","year":"2018","unstructured":"Poletti B, Carelli L, Faini A, Solca F, Meriggi P, Lafronza A, et al. The Arrows and Colors Cognitive Test (ACCT): a new verbal-motor free cognitive measure for executive functions in ALS. PLoS ONE. 2018;13:e0200953.","journal-title":"PLoS ONE"},{"key":"820_CR109","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1468-1331.2011.03501.x","volume":"19","author":"PM Andersen","year":"2012","unstructured":"Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical Management of Amyotrophic Lateral Sclerosis (MALS): revised report of an EFNS task force: EFNS Task Force on Management of ALS. Eur J Neurol. 2012;19:360\u201375.","journal-title":"Eur J Neurol."},{"key":"820_CR110","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/jnnp-2014-309601","volume":"86","author":"J Rooney","year":"2015","unstructured":"Rooney J, Byrne S, Heverin M, Tobin K, Dick A, Donaghy C, et al. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland. J Neurol Neurosurg Psychiatry. 2015;86:496\u2013501.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR111","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1136\/jnnp.2008.163246","volume":"80","author":"MC McElhiney","year":"2009","unstructured":"McElhiney MC, Rabkin JG, Gordon PH, Goetz R, Mitsumoto H. Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry. 2009;80:1146\u20139.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR112","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/ene.13246","volume":"24","author":"F Pagnini","year":"2017","unstructured":"Pagnini F, Marconi A, Tagliaferri A, Manzoni GM, Gatto R, Fabiani V, et al. Meditation training for people with amyotrophic lateral sclerosis: a randomized clinical trial. Eur J Neurol. 2017;24:578\u201386.","journal-title":"Eur J Neurol."},{"key":"820_CR113","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3109\/21678421.2015.1038276","volume":"16","author":"AC van Groenestijn","year":"2015","unstructured":"van Groenestijn AC, Schr\u00f6der CD, Visser-Meily JMA, Reenen ETK-V, Veldink JH, van den Berg LH. Cognitive behavioural therapy and quality of life in psychologically distressed patients with amyotrophic lateral sclerosis and their caregivers: results of a prematurely stopped randomized controlled trial. Amyotroph Lateral Scler Front Degener. 2015;16:309\u201315.","journal-title":"Amyotroph Lateral Scler Front Degener."},{"key":"820_CR114","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/MRR.0000000000000187","volume":"39","author":"A Raglio","year":"2016","unstructured":"Raglio A, Giovanazzi E, Pain D, Baiardi P, Imbriani C, Imbriani M, et al. Active music therapy approach in amyotrophic lateral sclerosis: a randomized-controlled trial. Int J Rehabil Res. 2016;39:365\u20137.","journal-title":"Int J Rehabil Res."},{"key":"820_CR115","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/153331750301800410","volume":"18","author":"R Moretti","year":"2003","unstructured":"Moretti R, Torre P, Antonello RM, Cazzato G, Griggio S, Bava A. Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer\u2019s disease and other dementias: a 24-month follow-up of 68 patients. Am J Alzheimers Dis Other Demen. 2003;18:205\u201314.","journal-title":"Am J Alzheimers Dis Other Demen."},{"key":"820_CR116","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJMoa061240","volume":"355","author":"LS Schneider","year":"2006","unstructured":"Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer\u2019s disease. N Engl J Med. 2006;355:1525\u201338.","journal-title":"N Engl J Med."},{"key":"820_CR117","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/jnc.13640","volume":"138","author":"RM Tsai","year":"2016","unstructured":"Tsai RM, Boxer AL. Therapy and clinical trials in frontotemporal dementia: past, present, and future. J Neurochem. 2016;138:211\u201321.","journal-title":"J Neurochem."},{"key":"820_CR118","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000077171","volume":"17","author":"F Lebert","year":"2004","unstructured":"Lebert F, Stekke W, Hasenbroekx C, Pasquier F. Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord. 2004;17:355\u20139.","journal-title":"Dement Geriatr Cogn Disord."},{"key":"820_CR119","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1212\/WNL.0000000000001133","volume":"84","author":"EC Finger","year":"2015","unstructured":"Finger EC, MacKinley J, Blair M, Oliver LD, Jesso S, Tartaglia MC, et al. Oxytocin for frontotemporal dementia: a randomized dose-finding study of safety and tolerability. Neurology. 2015;84:174\u201381.","journal-title":"Neurology"},{"key":"820_CR120","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ana.20828","volume":"59","author":"HS Panitch","year":"2006","unstructured":"Panitch HS, Thisted RA, Smith RA, Wynn DR, Wymer JP, Achiron A, et al. Randomized, controlled trial of dextromethorphan\/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol. 2006;59:780\u20137.","journal-title":"Ann Neurol."},{"key":"820_CR121","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/ana.22093","volume":"68","author":"EP Pioro","year":"2010","unstructured":"Pioro EP, Brooks BR, Cummings J, Schiffer R, Thisted RA, Wynn D, et al. Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol. 2010;68:693\u2013702.","journal-title":"Ann Neurol."},{"key":"820_CR122","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3233\/JAD-160222","volume":"56","author":"MAEK Emon","year":"2017","unstructured":"Emon MAEK, Kodamullil AT, Karki R, Younesi E, Hofmann-Apitius M. Using drugs as molecular probes: a computational chemical biology approach in neurodegenerative diseases. J Alzheimers Dis. 2017;56:677\u201386.","journal-title":"J Alzheimers Dis."},{"key":"820_CR123","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/clpt.1993.206","volume":"54","author":"FH Norris","year":"1993","unstructured":"Norris FH, Tan Y, Fallat RJ, Elias L. Trial of oral physostigmine in amyotrophic lateral sclerosis. Clin Pharmacol Ther. 1993;54:680\u20132.","journal-title":"Clin Pharmacol Ther."},{"key":"820_CR124","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000113034","volume":"25","author":"A Kertesz","year":"2008","unstructured":"Kertesz A, Morlog D, Light M, Blair M, Davidson W, Jesso S, et al. Galantamine in frontotemporal dementia and primary progressive aphasia. Dement Geriatr Cogn Disord. 2008;25:178\u201385.","journal-title":"Dement Geriatr Cogn Disord."},{"key":"820_CR125","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/01.JGP.0000231744.69631.33","volume":"15","author":"MF Mendez","year":"2007","unstructured":"Mendez MF, Shapira JS, McMurtray A, Licht E. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry. 2007;15:84\u20137.","journal-title":"Am J Geriatr Psychiatry."},{"key":"820_CR126","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3109\/17482968.2010.498521","volume":"11","author":"M de Carvalho","year":"2010","unstructured":"de Carvalho M, Pinto S, Costa J, Evangelista T, Ohana B, Pinto A. A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:456\u201360.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR127","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/jnnp.71.4.482","volume":"71","author":"I Newsom-Davis","year":"2001","unstructured":"Newsom-Davis I, Lyall R, Leigh P, Moxham J, Goldstein L. The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study. J Neurol Neurosurg Psychiatry. 2001;71:482\u20137.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR128","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1136\/jnnp.2010.228007","volume":"82","author":"DL Coco","year":"2011","unstructured":"Coco DL, Mattaliano P, Spataro R, Mattaliano A, Bella VL. Sleep\u2013wake disturbances in patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:839\u201342.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR129","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/brain\/awh686","volume":"129","author":"C Kaufmann","year":"2006","unstructured":"Kaufmann C, Wehrle R, Wetter TC, Holsboer F, Auer DP, Pollm\u00e4cher T, et al. Brain activation and hypothalamic functional connectivity during human non-rapid eye movement sleep: an EEG\/fMRI study. Brain. 2006;129:655\u201367.","journal-title":"Brain"},{"key":"820_CR130","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/jnnp-2017-315795","volume":"88","author":"M Gorges","year":"2017","unstructured":"Gorges M, Vercruysse P, M\u00fcller H-P, Huppertz H-J, Rosenbohm A, Nagel G, et al. Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88:1033\u201341.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR131","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.smrv.2015.05.007","volume":"26","author":"RM Ahmed","year":"2016","unstructured":"Ahmed RM, Newcombe REA, Piper AJ, Lewis SJ, Yee BJ, Kiernan MC, et al. Sleep disorders and respiratory function in amyotrophic lateral sclerosis. Sleep Med Rev. 2016;26:33\u201342.","journal-title":"Sleep Med Rev."},{"key":"820_CR132","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/jnnp-2017-316515","volume":"89","author":"M Boentert","year":"2018","unstructured":"Boentert M, Glatz C, Helmle C, Okegwo A, Young P. Prevalence of sleep apnoea and capnographic detection of nocturnal hypoventilation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2018;89:418\u201324.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR133","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/17482960601029883","volume":"8","author":"A Atalaia","year":"2007","unstructured":"Atalaia A, Carvalho MD, Evangelista T, Pinto A. Sleep characteristics of amyotrophic lateral sclerosis in patients with preserved diaphragmatic function. Amyotroph Lateral Scler. 2007;8:101\u20135.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR134","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/ane.12593","volume":"135","author":"D Lo Coco","year":"2017","unstructured":"Lo Coco D, Puligheddu M, Mattaliano P, Congiu P, Borghero G, Fantini ML, et al. REM sleep behavior disorder and periodic leg movements during sleep in ALS. Acta Neurol Scand. 2017;135:219\u201324.","journal-title":"Acta Neurol Scand."},{"key":"820_CR135","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1002\/mds.23261","volume":"25","author":"DL Coco","year":"2010","unstructured":"Coco DL, Piccoli F, Bella VL. Restless legs syndrome in patients with amyotrophic lateral sclerosis. Mov Disord. 2010;25:2658\u201361.","journal-title":"Mov Disord."},{"key":"820_CR136","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.sleep.2016.05.016","volume":"26","author":"M Puligheddu","year":"2016","unstructured":"Puligheddu M, Congiu P, Aric\u00f2 D, Rundo F, Borghero G, Marrosu F, et al. Isolated rapid eye movement sleep without atonia in amyotrophic lateral sclerosis. Sleep Med. 2016;26:16\u201322.","journal-title":"Sleep Med."},{"key":"820_CR137","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1017\/cjn.2014.39","volume":"41","author":"H Daoud","year":"2014","unstructured":"Daoud H, Postuma RB, Bourassa CV, Rochefort D, Gauthier MT, Montplaisir J, et al. C9orf72 repeat expansions in rapid eye movement sleep behaviour disorder. Can J Neurol Sci. 2014;41:759\u201362.","journal-title":"Can J Neurol Sci."},{"key":"820_CR138","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3109\/17482968.2012.673172","volume":"13","author":"MR Ebben","year":"2012","unstructured":"Ebben MR, Shahbazi M, Lange DJ, Krieger AC. REM behavior disorder associated with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13:473\u20134.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR139","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/sleep\/15.4.376","volume":"15","author":"MW Johns","year":"1992","unstructured":"Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992;15:376\u201381.","journal-title":"Sleep"},{"key":"820_CR140","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1207\/s15402010bsm0304_4","volume":"3","author":"VI Spoormaker","year":"2005","unstructured":"Spoormaker VI, Verbeek I, van den Bout J, Klip EC. Initial validation of the SLEEP-50 Questionnaire. Behav Sleep Med. 2005;3:227\u201346.","journal-title":"Behav Sleep Med."},{"key":"820_CR141","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S1389-9457(01)00131-9","volume":"3","author":"T Roth","year":"2002","unstructured":"Roth T, Zammit G, Kushida C, Doghramji K, Mathias SD, Wong JM, et al. A new questionnaire to detect sleep disorders. Sleep Med. 2002;3:99\u2013108.","journal-title":"Sleep Med."},{"key":"820_CR142","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11920-017-0816-4","volume":"19","author":"A Wichniak","year":"2017","unstructured":"Wichniak A, Wierzbicka A, Wal\u0119cka M, Jernajczyk W. Effects of antidepressants on sleep. Curr Psychiatry Rep. 2017;19:63.","journal-title":"Curr Psychiatry Rep."},{"key":"820_CR143","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/01616412.2017.1315864","volume":"39","author":"Z Xie","year":"2017","unstructured":"Xie Z, Chen F, Li WA, Geng X, Li C, Meng X, et al. A review of sleep disorders and melatonin. Neurol Res. 2017;39:559\u201365.","journal-title":"Neurol Res."},{"key":"820_CR144","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1183\/09031936.93.06050625","volume":"6","author":"D Murciano","year":"1993","unstructured":"Murciano D, Armengaud MH, Cramer PH, Neveux E, L\u2019Heritier C, Pariente R, et al. Acute effects of zolpidem, triazolam and flunitrazepam on arterial blood gases and control of breathing in severe COPD. Eur Respir J. 1993;6:625\u20139.","journal-title":"Eur Respir J."},{"key":"820_CR145","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.sleep.2008.06.005","volume":"10","author":"T Roth","year":"2009","unstructured":"Roth T. Hypnotic use for insomnia management in chronic obstructive pulmonary disease. Sleep Med. 2009;10:19\u201325.","journal-title":"Sleep Med."},{"issue":"5","key":"820_CR146","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/02791072.2019.1643053","volume":"51","author":"BR Altman","year":"2019","unstructured":"Altman BR, Mian MN, Slavin M, Earleywine M. Cannabis expectancies for sleep. J Psychoactive Drugs. 2019;51(5):405\u201312.","journal-title":"J Psychoactive Drugs."},{"key":"820_CR147","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3389\/fphar.2018.01513","volume":"9","author":"S-H Wang","year":"2019","unstructured":"Wang S-H, Chen W-S, Tang S-E, Lin H-C, Peng C-K, Chu H-T, et al. Benzodiazepines associated with acute respiratory failure in patients with obstructive sleep apnea. Front Pharmacol. 2019;9:1513.","journal-title":"Front Pharmacol."},{"key":"820_CR148","first-page":"CCD011090","volume":"7","author":"M Mason","year":"2015","unstructured":"Mason M, Cates CJ, Smith I. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea. Cochrane Database Syst Rev. 2015;7:CCD011090.","journal-title":"Cochrane Database Syst Rev."},{"issue":"11","key":"820_CR149","first-page":"175628561773473","volume":"9","author":"J Dorst","year":"2017","unstructured":"Dorst J, Ludolph AC, Huebers A. Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis. Ther Adv Neurol Disord. 2017;9(11):1756285617734734.","journal-title":"Ther Adv Neurol Disord."},{"key":"820_CR150","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5664\/jcsm.4704","volume":"11","author":"B Vrijsen","year":"2015","unstructured":"Vrijsen B, Buyse B, Belge C, Robberecht W, Damme PV, Decramer M, et al. Noninvasive ventilation improves sleep in amyotrophic lateral sclerosis: a prospective polysomnographic study. J Clin Sleep Med. 2015;11:559\u201366.","journal-title":"J Clin Sleep Med."},{"key":"820_CR151","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/mus.24457","volume":"51","author":"EA Piccione","year":"2015","unstructured":"Piccione EA, Sletten DM, Staff NP, Low PA. Autonomic system and amyotrophic lateral sclerosis. Muscle Nerve. 2015;51:676\u20139.","journal-title":"Muscle Nerve."},{"key":"820_CR152","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/neup.12303","volume":"36","author":"K Hayashi","year":"2016","unstructured":"Hayashi K, Mochizuki Y, Koide R, Kawata A, Homma T, Shimizu T, et al. A Japanese familial ALS patient with autonomic failure and a p.Cys146Arg mutation in the gene for SOD1 ( SOD1): SOD1 mutant FALS with autonomic failure. Neuropathology. 2016;36:551\u20135.","journal-title":"Neuropathology"},{"key":"820_CR153","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1001\/jamaneurol.2013.5762","volume":"71","author":"JS Goldman","year":"2014","unstructured":"Goldman JS, Quinzii C, Dunning-Broadbent J, Waters C, Mitsumoto H, Brannagan TH, et al. Multiple system atrophy and amyotrophic lateral sclerosis in a family with hexanucleotide repeat expansions in C9orf72. JAMA Neurol. 2014;71:771.","journal-title":"JAMA Neurol."},{"key":"820_CR154","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0022-510X(94)90009-4","volume":"124","author":"T Shimizu","year":"1994","unstructured":"Shimizu T, Hayashi H, Kato S, Hayashi M, Tanabe H, Oda M. Circulatory collapse and sudden death in respirator-dependent amyotrophic lateral sclerosis. J Neurol Sci. 1994;124:45\u201355.","journal-title":"J Neurol Sci."},{"key":"820_CR155","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/nau.22976","volume":"36","author":"S Arlandis","year":"2017","unstructured":"Arlandis S, V\u00e1zquez-Costa JF, Mart\u00ednez-Cuenca E, Sevilla T, Boronat F, Broseta E. Urodynamic findings in amyotrophic lateral sclerosis patients with lower urinary tract symptoms: results from a pilot study. Neurourol Urodyn. 2017;36:626\u201331.","journal-title":"Neurourol Urodyn."},{"key":"820_CR156","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3109\/17482968.2011.574141","volume":"12","author":"MLL de Carvalho","year":"2011","unstructured":"de Carvalho MLL, Motta R, Battaglia MA, Brichetto G. Urinary disorders in amyotrophic lateral sclerosis subjects. Amyotroph Lateral Scler. 2011;12:352\u20135.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR157","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3109\/21678421.2013.868001","volume":"15","author":"GS N\u00fcbling","year":"2014","unstructured":"N\u00fcbling GS, Mie E, Bauer RM, Hensler M, Lorenzl S, Hapfelmeier A, et al. Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2014;15:174\u20139.","journal-title":"Amyotroph Lateral Scler Front Degener."},{"key":"820_CR158","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jns.2017.04.053","volume":"378","author":"JF V\u00e1zquez-Costa","year":"2017","unstructured":"V\u00e1zquez-Costa JF, Arlandis S, Hervas D, Mart\u00ednez-Cuenca E, Cardona F, P\u00e9rez-Tur J, et al. Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder. J Neurol Sci. 2017;378:130\u20136.","journal-title":"J Neurol Sci."},{"key":"820_CR159","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/146608299300079484","volume":"1","author":"M Toepfer","year":"2000","unstructured":"Toepfer M, Folwaczny C, Klauser A, Riepl RL, Muller-Felber W, M\u00fcller-Felber W, et al. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:15\u20139.","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord."},{"key":"820_CR160","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3109\/21678421.2013.790452","volume":"14","author":"EV Hobson","year":"2013","unstructured":"Hobson EV, McGeachan A, Al-Chalabi A, Chandran S, Crawley F, Dick D, et al. Management of sialorrhoea in motor neuron disease: a survey of current UK practice. Amyotroph Lateral Scler Front Degener. 2013;14:521\u20137.","journal-title":"Amyotroph Lateral Scler Front Degener."},{"key":"820_CR161","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1007\/s00415-002-0820-3","volume":"249","author":"R Giess","year":"2002","unstructured":"Giess R, Werner E, Beck M, Reiners C, Toyka KV, Naumann M. Impaired salivary gland function reveals autonomic dysfunction in amyotrophic lateral sclerosis. J Neurol. 2002;249:1246\u20139.","journal-title":"J Neurol."},{"key":"820_CR162","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/mus.880181103","volume":"18","author":"F Pisano","year":"1995","unstructured":"Pisano F, Miscio G, Mazzuero G, Lanfranchi P, Colombo R, Pinelli P. Decreased heart rate variability in amyotrophic lateral sclerosis. Muscle Nerve. 1995;18:1225\u201331.","journal-title":"Muscle Nerve."},{"key":"820_CR163","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/01.wco.0000183114.76056.0e","volume":"18","author":"R Baltadzhieva","year":"2005","unstructured":"Baltadzhieva R, Gurevich T, Korczyn AD. Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2005;18:487\u201393.","journal-title":"Curr Opin Neurol."},{"key":"820_CR164","doi-asserted-by":"publisher","first-page":"972","DOI":"10.2169\/internalmedicine.34.972","volume":"34","author":"K Sato","year":"1995","unstructured":"Sato K, Namba R, Hayabara T, Kashihara K, Morimoto K. Autonomic nervous disorder in motor neuron disease: a study of advanced stage patients. Intern Med. 1995;34:972\u20135.","journal-title":"Intern Med."},{"key":"820_CR165","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3109\/17482960903390855","volume":"11","author":"S Pavlovic","year":"2010","unstructured":"Pavlovic S, Stevic Z, Milovanovic B, Milicic B, Rakocevic-Stojanovic V, Lavrnic D, et al. Impairment of cardiac autonomic control in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:272\u20136.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR166","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1136\/jnnp.73.1.68","volume":"73","author":"M Beck","year":"2002","unstructured":"Beck M, Giess R, Magnus T, Puls I, Reiners K, Toyka KV, et al. Progressive sudomotor dysfunction in amyotrophic lateral sclerosis. J Neurol Neurosurg Amp Psychiatry. 2002;73:68.","journal-title":"J Neurol Neurosurg Amp Psychiatry."},{"key":"820_CR167","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","volume":"87","author":"DM Sletten","year":"2012","unstructured":"Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc. 2012;87:1196\u2013201.","journal-title":"Mayo Clin Proc."},{"key":"820_CR168","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/14660820510028412","volume":"6","author":"M Beck","year":"2005","unstructured":"Beck M, Flachenecker P, Magnus T, Giess R, Reiners K, Toyka KV, et al. Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF. Amyotroph Lateral Scler. 2005;6:100\u20133.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR169","doi-asserted-by":"publisher","first-page":"iv27","DOI":"10.1136\/jnnp.74.suppl_4.iv27","volume":"74","author":"CJ Fowler","year":"2003","unstructured":"Fowler CJ, O\u2019Malley KJ. Investigation and management of neurogenic bladder dysfunction. J Neurol Neurosurg Psychiatry. 2003;74:iv27-31.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR170","first-page":"1230","volume":"94","author":"D Patterson","year":"1999","unstructured":"Patterson D, Abell T, Rothstein R, Koch K, Barnett J. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol. 1999;94:1230\u20134.","journal-title":"Am J Gastroenterol."},{"key":"820_CR171","doi-asserted-by":"publisher","first-page":"446","DOI":"10.4187\/respcare.02856","volume":"60","author":"P Banfi","year":"2015","unstructured":"Banfi P, Ticozzi N, Lax A, Guidugli GA, Nicolini A, Silani V. A review of options for treating sialorrhea in amyotrophic lateral sclerosis. Respir Care. 2015;60:446\u201354.","journal-title":"Respir Care."},{"key":"820_CR172","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1212\/WNL.0b013e3181d8c1b7","volume":"74","author":"MEL Arbouw","year":"2010","unstructured":"Arbouw MEL, Movig KLL, Koopmann M, Poels PJE, Guchelaar H-J, Egberts TCG, et al. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial. Neurology. 2010;74:1203\u20137.","journal-title":"Neurology"},{"key":"820_CR173","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0885-3924(01)00378-5","volume":"23","author":"R Strutt","year":"2002","unstructured":"Strutt R, Fardell B, Chye R. Nebulized glycopyrrolate for drooling in a motor neuron patient. J Pain Symptom Manage. 2002;23:2\u20133.","journal-title":"J Pain Symptom Manage."},{"key":"820_CR174","doi-asserted-by":"publisher","first-page":"1365401","DOI":"10.1080\/2331205X.2017.1365401","volume":"4","author":"K Odachi","year":"2017","unstructured":"Odachi K, Narita Y, Machino Y, Yamada T, Nishimura Y, Ota Y, et al. Efficacy of transdermal scopolamine for sialorrhea in patients with amyotrophic lateral sclerosis. Cogent Med. 2017;4:1365401.","journal-title":"Cogent Med."},{"key":"820_CR175","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/mus.21213","volume":"39","author":"CE Jackson","year":"2009","unstructured":"Jackson CE, Gronseth G, Rosenfeld J, Barohn RJ, Dubinsky R, Simpson CB, et al. Randomized double-blind study of botulinum toxin type B for sialorrhea in als patients. Muscle Nerve. 2009;39:137\u201343.","journal-title":"Muscle Nerve."},{"key":"820_CR176","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1212\/WNL.61.9.1279","volume":"61","author":"A Lipp","year":"2003","unstructured":"Lipp A, Trottenberg T, Schink T, Kupsch A, Arnold G. A randomized trial of botulinum toxin A for treatment of drooling. Neurology. 2003;61:1279\u201381.","journal-title":"Neurology"},{"key":"820_CR177","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mds.23473","volume":"26","author":"A Guidubaldi","year":"2011","unstructured":"Guidubaldi A, Fasano A, Ialongo T, Piano C, Pompili M, Mascian\u00e0 R, et al. Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson\u2019s disease. Mov Disord. 2011;26:313\u20139.","journal-title":"Mov Disord."},{"key":"820_CR178","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1001\/jamaneurol.2019.4565","volume":"77","author":"SH Isaacson","year":"2020","unstructured":"Isaacson SH, Ondo W, Jackson CE, Trosch RM, Molho E, Pagan F, et al. Safety and efficacy of rimabotulinumtoxinB for treatment of sialorrhea in adults: a randomized clinical trial. JAMA Neurol. 2020;77:461.","journal-title":"JAMA Neurol."},{"key":"820_CR179","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/lary.25444","volume":"126","author":"NM Hawkey","year":"2016","unstructured":"Hawkey NM, Zaorsky NG, Galloway TJ. The role of radiation therapy in the management of sialorrhea: a systematic review. Laryngoscope. 2016;126:80\u20135.","journal-title":"Laryngoscope."},{"key":"820_CR180","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ijrobp.2013.11.230","volume":"88","author":"A Assouline","year":"2014","unstructured":"Assouline A, Levy A, Abdelnour-Mallet M, Gonzalez-Bermejo J, Lenglet T, Le Forestier N, et al. Radiation therapy for hypersalivation: a prospective study in 50 amyotrophic lateral sclerosis patients. Int J Radiat Oncol. 2014;88:589\u201395.","journal-title":"Int J Radiat Oncol."},{"key":"820_CR181","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11882-009-0015-4","volume":"9","author":"W Storms","year":"2009","unstructured":"Storms W, Farrar JR. Guaifenesin in rhinitis. Curr Allergy Asthma Rep. 2009;9:101\u20136.","journal-title":"Curr Allergy Asthma Rep."},{"key":"820_CR182","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1749-6632.1963.tb16647.x","volume":"106","author":"AL Sheffner","year":"2008","unstructured":"Sheffner AL. The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent. N-acetyl-L-cysteine Ann N Y Acad Sci. 2008;106:298\u2013310.","journal-title":"N-acetyl-L-cysteine. Ann N Y Acad Sci."},{"issue":"9","key":"820_CR183","first-page":"CD001506","volume":"9","author":"P Wark","year":"2018","unstructured":"Wark P, McDonald VM. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst Rev. 2018;9(9):CD001506.","journal-title":"Cochrane Database Syst Rev."},{"key":"820_CR184","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/21678421.2015.1074701","volume":"17","author":"HE Stephens","year":"2016","unstructured":"Stephens HE, Lehman E, Raheja D, Yang C, Walsh S, Mcarthur DB, et al. Pain in amyotrophic lateral sclerosis: patient and physician perspectives and practices. Amyotroph Lateral Scler Front Degener. 2016;17:21\u20139.","journal-title":"Amyotroph Lateral Scler Front Degener."},{"key":"820_CR185","first-page":"115","volume":"28","author":"A Pizzimenti","year":"2013","unstructured":"Pizzimenti A, Aragona M, Onesti E, Inghilleri M. Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study. Funct Neurol. 2013;28:115\u20139.","journal-title":"Funct Neurol."},{"key":"820_CR186","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1093\/brain\/awv276","volume":"138","author":"PD Fletcher","year":"2015","unstructured":"Fletcher PD, Downey LE, Golden HL, Clark CN, Slattery CF, Paterson RW, et al. Pain and temperature processing in dementia: a clinical and neuroanatomical analysis. Brain. 2015;138:3360\u201372.","journal-title":"Brain"},{"key":"820_CR187","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1474-4422(16)30358-1","volume":"16","author":"A Chi\u00f2","year":"2017","unstructured":"Chi\u00f2 A, Mora G, Lauria G. Pain in amyotrophic lateral sclerosis. Lancet Neurol. 2017;16:144\u201357.","journal-title":"Lancet Neurol."},{"key":"820_CR188","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/mus.24892","volume":"53","author":"JB Caress","year":"2016","unstructured":"Caress JB, Ciarlone SL, Sullivan EA, Griffin LP, Cartwright MS. Natural history of muscle cramps in amyotrophic lateral sclerosis. Muscle Nerve. 2016;53:513\u20137.","journal-title":"Muscle Nerve."},{"key":"820_CR189","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/17482960701642502","volume":"9","author":"C Ramirez","year":"2008","unstructured":"Ramirez C, Piemonte MEP, Callegaro D, Silva HCAD. Fatigue in amyotrophic lateral sclerosis: frequency and associated factors. Amyotroph Lateral Scler. 2008;9:75\u201380.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR190","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1212\/01.WNL.0000042781.22278.0A","volume":"60","author":"J-S Lou","year":"2003","unstructured":"Lou J-S, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003;60:122\u20133.","journal-title":"Neurology"},{"key":"820_CR191","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1212\/WNL.45.4.733","volume":"45","author":"KR Sharma","year":"1995","unstructured":"Sharma KR, Kent- Braun JA, Majumdar S, Huang Y, Mynhier M, Weiner MW, et al. Physiology of fatigue in amyotrophic lateral sclerosis. Neurology. 1995;45:733\u201340.","journal-title":"Neurology"},{"key":"820_CR192","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0022-510X(01)00624-4","volume":"191","author":"M Sanjak","year":"2001","unstructured":"Sanjak M, Brinkmann J, Belden DS, Roelke K, Waclawik A, Neville HE, et al. Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis. J Neurol Sci. 2001;191:55\u20139.","journal-title":"J Neurol Sci."},{"key":"820_CR193","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/jnnp.2006.112078","volume":"78","author":"S Vucic","year":"2007","unstructured":"Vucic S, Krishnan AV, Kiernan MC. Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis. J Neurol Neurosurg Amp Psychiatry. 2007;78:1202\u20138.","journal-title":"J Neurol Neurosurg Amp Psychiatry."},{"issue":"2","key":"820_CR194","first-page":"129","volume":"23","author":"C Cleeland","year":"1994","unstructured":"Cleeland C, Ryan K. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994;23(2):129\u201338.","journal-title":"Ann Acad Med Singap."},{"key":"820_CR195","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3109\/21678421.2014.951944","volume":"15","author":"VCJ Wallace","year":"2014","unstructured":"Wallace VCJ, Ellis CM, Burman R, Knights C, Shaw CE, Al-Chalabi A. The evaluation of pain in amyotrophic lateral sclerosis: a case controlled observational study. Amyotroph Lateral Scler Front Degener. 2014;15:520\u20137.","journal-title":"Amyotroph Lateral Scler Front Degener."},{"key":"820_CR196","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EM Smets","year":"1995","unstructured":"Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315\u201325.","journal-title":"J Psychosom Res."},{"issue":"Suppl. 3","key":"820_CR197","doi-asserted-by":"publisher","first-page":"S198","DOI":"10.1016\/j.nmd.2012.10.013","volume":"22","author":"A Abraham","year":"2012","unstructured":"Abraham A, Drory VE. Fatigue in motor neuron diseases. Neuromuscul Disord. 2012;22(Suppl. 3):S198-202.","journal-title":"Neuromuscul Disord."},{"key":"820_CR198","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/1097-4598(200103)24:3<403::AID-MUS1013>3.0.CO;2-3","volume":"24","author":"LS Aboussouan","year":"2001","unstructured":"Aboussouan LS, Khan SU, Banerjee M, Arroliga AC, Mitsumoto H. Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve. 2001;24:403\u20139.","journal-title":"Muscle Nerve."},{"key":"820_CR199","first-page":"CD005226","volume":"3","author":"J Brettschneider","year":"2008","unstructured":"Brettschneider J, Kurent J, Ludolph A, Mitchell JD. Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev. 2008;3:CD005226.","journal-title":"Cochrane Database Syst Rev."},{"key":"820_CR200","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/jnnp.48.8.838","volume":"48","author":"PG Newrick","year":"1985","unstructured":"Newrick PG, Langton-Hewer R. Pain in motor neuron disease. J Neurol Neurosurg Psychiatry. 1985;48:838\u201340.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR201","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mus.20900","volume":"37","author":"S McClelland","year":"2008","unstructured":"McClelland S, Bethoux FA, Boulis NM, Sutliff MH, Stough DK, Schwetz KM, et al. Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief. Muscle Nerve. 2008;37:396\u20138.","journal-title":"Muscle Nerve."},{"key":"820_CR202","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/17482960802430773","volume":"10","author":"RS Bedlack","year":"2009","unstructured":"Bedlack RS, Pastula DM, Hawes J, Heydt D. Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. Amyotroph Lateral Scler. 2009;10:210\u20135.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR203","doi-asserted-by":"publisher","first-page":"g445","DOI":"10.1136\/bmj.g445","volume":"348","author":"MP Ekstr\u00f6m","year":"2014","unstructured":"Ekstr\u00f6m MP, Bornefalk-Hermansson A, Abernethy AP, Currow DC. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ. 2014;348:g445.","journal-title":"BMJ"},{"key":"820_CR204","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/104990910402100206","volume":"21","author":"D Amtmann","year":"2004","unstructured":"Amtmann D, Weydt P, Johnson KL, Jensen MP, Carter GT. Survey of cannabis use in patients with amyotrophic lateral sclerosis. Am J Hosp Palliat Med. 2004;21:95\u2013104.","journal-title":"Am J Hosp Palliat Med."},{"key":"820_CR205","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1474-4422(18)30406-X","volume":"18","author":"N Riva","year":"2019","unstructured":"Riva N, Mora G, Sorar\u00f9 G, Lunetta C, Ferraro OE, Falzone Y, et al. Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2019;18:155\u201364.","journal-title":"Lancet Neurol."},{"key":"820_CR206","first-page":"CD005044","volume":"4","author":"S El-Tawil","year":"2015","unstructured":"El-Tawil S, Musa TA, Valli H, Lunn MP, Brassington R, El-Tawil T, et al. Quinine for muscle cramps. Cochrane Database Syst Rev. 2015;4:CD005044.","journal-title":"Cochrane Database Syst Rev."},{"key":"820_CR207","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1212\/WNL.0b013e3181d0ccca","volume":"74","author":"HD Katzberg","year":"2010","unstructured":"Katzberg HD, Khan AH, So YT. Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2010;74:691\u20136.","journal-title":"Neurology"},{"key":"820_CR208","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2009.200642","volume":"81","author":"M Weber","year":"2010","unstructured":"Weber M, Goldman B, Truniger S. Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial. J Neurol Neurosurg Psychiatry. 2010;81:1135\u201340.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR209","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1212\/WNL.0000000000002507","volume":"86","author":"MD Weiss","year":"2016","unstructured":"Weiss MD, Macklin EA, Simmons Z, Knox AS, Greenblatt DJ, Atassi N, et al. A randomized trial of mexiletine in ALS: safety and effects on muscle cramps and progression. Neurology. 2016;86:1474\u201381.","journal-title":"Neurology"},{"key":"820_CR210","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1089\/acu.2017.1241","volume":"29","author":"P Sudhakaran","year":"2017","unstructured":"Sudhakaran P. Amyotrophic lateral sclerosis: an acupuncture approach. Med Acupunct. 2017;29:260\u20138.","journal-title":"Med Acupunct."},{"key":"820_CR211","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1874205X01610010059","volume":"10","author":"A Maggiani","year":"2016","unstructured":"Maggiani A, Tremolizzo L, Valentina AD, Mapelli L, Sosio S, Milano V, et al. Osteopathic manual treatment for amyotrophic lateral sclerosis: a feasibility pilot Study. Open Neurol J. 2016;10:59\u201366.","journal-title":"Open Neurol J."},{"key":"820_CR212","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/104990910502200112","volume":"22","author":"GT Carter","year":"2005","unstructured":"Carter GT, Weiss MD, Lou J-S, Jensen MP, Abresch RT, Martin TK, et al. Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study. Am J Hosp Palliat Care. 2005;22:55\u20139.","journal-title":"Am J Hosp Palliat Care."},{"key":"820_CR213","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mus.21245","volume":"39","author":"JG Rabkin","year":"2009","unstructured":"Rabkin JG, Gordon PH, McElhiney M, Rabkin R, Chew S, Mitsumoto H. Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study. Muscle Nerve. 2009;39:297\u2013303.","journal-title":"Muscle Nerve."},{"key":"820_CR214","first-page":"88","volume":"5","author":"M M\u00fccke","year":"2015","unstructured":"M\u00fccke M, Mochamat, Cuhls H, Peuckmann-Post V, Minton O, Stone P, et al. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev. 2015;5:88.","journal-title":"Cochrane Database Syst Rev."},{"key":"820_CR215","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1212\/01.wnl.0000264418.92308.a4","volume":"68","author":"VD Bello-Haas","year":"2007","unstructured":"Bello-Haas VD, Florence JM, Kloos AD, Scheirbecker J, Lopate G, Hayes SM, et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology. 2007;68:2003\u20137.","journal-title":"Neurology"},{"key":"820_CR216","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jns.2008.01.011","volume":"270","author":"G Zanette","year":"2008","unstructured":"Zanette G, Forgione A, Manganotti P, Fiaschi A, Tamburin S. The effect of repetitive transcranial magnetic stimulation on motor performance, fatigue and quality of life in amyotrophic lateral sclerosis. J Neurol Sci. 2008;270:18\u201322.","journal-title":"J Neurol Sci."},{"key":"820_CR217","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/acn3.765","volume":"6","author":"E Zucchi","year":"2019","unstructured":"Zucchi E, Vinceti M, Malagoli C, Fini N, Gessani A, Fasano A, et al. High-frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial. Ann Clin Transl Neurol. 2019;6:893\u2013901.","journal-title":"Ann Clin Transl Neurol."},{"key":"820_CR218","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/ajcn\/74.3.328","volume":"74","author":"JC Desport","year":"2001","unstructured":"Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufr\u00e8re B, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74:328\u201334.","journal-title":"Am J Clin Nutr."},{"key":"820_CR219","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00415-016-8168-2","volume":"263","author":"RM Ahmed","year":"2016","unstructured":"Ahmed RM, Caga J, Devenney E, Hsieh S, Bartley L, Highton-Williamson E, et al. Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival. J Neurol. 2016;263:1593\u2013603.","journal-title":"J Neurol."},{"key":"820_CR220","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/jnnp-2017-317887","volume":"89","author":"FJ Steyn","year":"2018","unstructured":"Steyn FJ, Ioannides ZA, van Eijk RPA, Heggie S, Thorpe KA, Ceslis A, et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry. 2018;89:1016\u201323.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR221","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/jnnp-2018-319611","volume":"90","author":"C Moglia","year":"2019","unstructured":"Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D\u2019Ovidio F, et al. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry. 2019;90:666\u201373.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR222","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1136\/jnnp-2020-322909","volume":"91","author":"JMR van Mantgem","year":"2020","unstructured":"van Mantgem JMR, van Eijk RPA, van der Burgh HK, Tan HHG, Westeneng H-J, van Es MA, et al. Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2020;91:867\u201375.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR223","doi-asserted-by":"publisher","first-page":"e424","DOI":"10.1212\/WNL.0000000000007861","volume":"93","author":"O Nakken","year":"2019","unstructured":"Nakken O, Meyer HE, Stigum H, Holm\u00f8y T. High BMI is associated with low ALS risk: a population-based study. Neurology. 2019;93:e424\u201332.","journal-title":"Neurology"},{"key":"820_CR224","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","volume":"70","author":"L Dupuis","year":"2008","unstructured":"Dupuis L, Corcia P, Fergani A, De Aguilar GJ-L, Bonnefont-Rousselot D, Bittar R, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004\u20139.","journal-title":"Neurology"},{"key":"820_CR225","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrneurol.2018.23","volume":"14","author":"RM Ahmed","year":"2018","unstructured":"Ahmed RM, Ke YD, Vucic S, Ittner LM, Seeley W, Hodges JR, et al. Physiological changes in neurodegeneration: mechanistic insights and clinical utility. Nat Rev Neurol. 2018;14:259\u201371.","journal-title":"Nat Rev Neurol."},{"key":"820_CR226","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","volume":"258","author":"J Dorst","year":"2011","unstructured":"Dorst J, K\u00fchnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol. 2011;258:613\u20137.","journal-title":"J Neurol."},{"key":"820_CR227","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1179\/1743132812Y.0000000049","volume":"34","author":"SIK Dedic","year":"2012","unstructured":"Dedic SIK, Stevic Z, Dedic V, Stojanovic VR, Milicev M, Lavrnic D. Is hyperlipidemia correlated with longer survival in patients with amyotrophic lateral sclerosis? Neurol Res. 2012;34:576\u201380.","journal-title":"Neurol Res."},{"key":"820_CR228","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3109\/17482960902822960","volume":"11","author":"P-F Pradat","year":"2010","unstructured":"Pradat P-F, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, Simon D, et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:166\u201371.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR229","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/ene.12632","volume":"22","author":"D Mariosa","year":"2015","unstructured":"Mariosa D, Kamel F, Bellocco R, Ye W, Fang F. Association between diabetes and amyotrophic lateral sclerosis in Sweden. Eur J Neurol. 2015;22:1436\u201342.","journal-title":"Eur J Neurol."},{"key":"820_CR230","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3389\/fendo.2018.00400","volume":"9","author":"C Rotermund","year":"2018","unstructured":"Rotermund C, Machetanz G, Fitzgerald JC. The Therapeutic potential of metformin in neurodegenerative diseases. Front Endocrinol. 2018;9:400.","journal-title":"Front Endocrinol."},{"key":"820_CR231","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/21678421.2017.1300287","volume":"18","author":"TL Peters","year":"2017","unstructured":"Peters TL, Weibull CE, Fang F, Sandler DP, Lambert PC, Ye W, et al. Association of fractures with the incidence of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2017;18:419\u201325.","journal-title":"Amyotroph Lateral Scler Front Degener."},{"key":"820_CR232","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/mus.25555","volume":"56","author":"S Paganoni","year":"2017","unstructured":"Paganoni S, Macklin EA, Karam C, Yu H, Gonterman F, Fetterman KA, et al. Vitamin D levels are associated with gross motor function in amyotrophic lateral sclerosis. Muscle Nerve. 2017;56:726\u201331.","journal-title":"Muscle Nerve."},{"key":"820_CR233","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/S0140-6736(14)60222-1","volume":"383","author":"A-M Wills","year":"2014","unstructured":"Wills A-M, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383:2065\u201372.","journal-title":"Lancet"},{"key":"820_CR234","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00415-015-7646-2","volume":"262","author":"J Dorst","year":"2015","unstructured":"Dorst J, Dupuis L, Petri S, Kollewe K, Abdulla S, Wolf J, et al. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study. J Neurol. 2015;262:849\u201358.","journal-title":"J Neurol."},{"key":"820_CR235","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.25661","volume":"87","author":"AC Ludolph","year":"2020","unstructured":"Ludolph AC, Dorst J, Dreyhaupt J, Weishaupt JH, Kassubek J, Weiland U, et al. Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis. Ann Neurol. 2020;87:206\u201316.","journal-title":"Ann Neurol."},{"key":"820_CR236","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/BF00866922","volume":"242","author":"L Mazzini","year":"1995","unstructured":"Mazzini L, Corr\u00e0 T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol. 1995;242:695\u20138.","journal-title":"J Neurol."},{"key":"820_CR237","first-page":"CD004030","volume":"1","author":"HD Katzberg","year":"2011","unstructured":"Katzberg HD, Benatar M. Enteral tube feeding for amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database Syst Rev. 2011;1:CD004030.","journal-title":"Cochrane Database Syst Rev."},{"key":"820_CR238","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s00415-014-7445-1","volume":"261","author":"M Seelen","year":"2014","unstructured":"Seelen M, van Doormaal PTC, Visser AE, Huisman MHB, Roozekrans MHJ, de Jong SW, et al. Prior medical conditions and the risk of amyotrophic lateral sclerosis. J Neurol. 2014;261:1949\u201356.","journal-title":"J Neurol."},{"key":"820_CR239","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40264-017-0620-4","volume":"41","author":"BA Golomb","year":"2018","unstructured":"Golomb BA, Verden A, Messner AK, Koslik HJ, Hoffman KB. Amyotrophic lateral sclerosis associated with statin use: a disproportionality analysis of the FDA\u2019s Adverse Event Reporting System. Drug Saf. 2018;41:403\u201313.","journal-title":"Drug Saf."},{"key":"820_CR240","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/17482960802031092","volume":"9","author":"L Zinman","year":"2008","unstructured":"Zinman L, Sadeghi R, Gawel M, Patton D, Kiss A. Are statin medications safe in patients with ALS? Amyotroph Lateral Scler. 2008;9:223\u20138.","journal-title":"Amyotroph Lateral Scler."},{"key":"820_CR241","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.jocn.2013.01.011","volume":"20","author":"C Karam","year":"2013","unstructured":"Karam C, Barrett MJ, Imperato T, MacGowan DJL, Scelsa S. Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis. J Clin Neurosci. 2013;20:1550\u20133.","journal-title":"J Clin Neurosci."},{"key":"820_CR242","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41430-019-0448-3","volume":"74","author":"F Trojsi","year":"2020","unstructured":"Trojsi F, Siciliano M, Passaniti C, Bisecco A, Russo A, Lavorgna L, et al. Vitamin D supplementation has no effects on progression of motor dysfunction in amyotrophic lateral sclerosis (ALS). Eur J Clin Nutr. 2020;74:167\u201375.","journal-title":"Eur J Clin Nutr."},{"key":"820_CR243","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrneurol.2014.184","volume":"10","author":"B Swinnen","year":"2014","unstructured":"Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10:661\u201370.","journal-title":"Nat Rev Neurol."},{"key":"820_CR244","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s00415-019-09305-0","volume":"266","author":"A Calvo","year":"2019","unstructured":"Calvo A, Chi\u00f2 A, Pagani M, Cammarosano S, Dematteis F, Moglia C, et al. Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study. J Neurol. 2019;266:1633\u201342.","journal-title":"J Neurol."},{"issue":"6","key":"820_CR245","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00401-011-0911-2","volume":"122","author":"S Al-Sarraj","year":"2011","unstructured":"Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND\/ALS. Acta Neuropathol. 2011;122(6):691\u2013702.","journal-title":"Acta Neuropathol."},{"key":"820_CR246","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/acn3.594","volume":"5","author":"C Viguera","year":"2018","unstructured":"Viguera C, Wang J, Mosmiller E, Cerezo A, Maragakis NJ. Olfactory dysfunction in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2018;5:976\u201381.","journal-title":"Ann Clin Transl Neurol."},{"key":"820_CR247","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fnagi.2014.00278","volume":"6","author":"G Ferrari","year":"2014","unstructured":"Ferrari G, Grisan E, Scarpa F, Fazio R, Comola M, Quattrini A, et al. Corneal confocal microscopy reveals trigeminal small sensory fiber neuropathy in amyotrophic lateral sclerosis. Front Aging Neurosci. 2014;6:278.","journal-title":"Front Aging Neurosci."},{"key":"820_CR248","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/jnnp-2014-307756","volume":"85","author":"S Vucic","year":"2014","unstructured":"Vucic S. Facial onset sensory motor neuronopathy (FOSMN) syndrome: an unusual amyotrophic lateral sclerosis phenotype? J Neurol Neurosurg Psychiatry. 2014;85:951\u2013951.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR249","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/jnnp-2018-318868","volume":"90","author":"P Oeckl","year":"2019","unstructured":"Oeckl P, Weydt P, Steinacker P, Anderl-Straub S, Nordin F, Volk AE, et al. Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase. J Neurol Neurosurg Psychiatry. 2019;90:4\u201310.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"820_CR250","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrgastro.2016.107","volume":"13","author":"M Rao","year":"2016","unstructured":"Rao M, Gershon MD. The bowel and beyond: the enteric nervous system in neurological disorders. Nat Rev Gastroenterol Hepatol. 2016;13:517\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"820_CR251","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00702-018-1851-y","volume":"125","author":"S Br\u00e4uer","year":"2018","unstructured":"Br\u00e4uer S, Zimyanin V, Hermann A. Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis. J Neural Transm. 2018;125:591\u2013613.","journal-title":"J Neural Transm."},{"key":"820_CR252","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-015-1514-0","volume":"131","author":"JI Ayers","year":"2016","unstructured":"Ayers JI, Fromholt SE, O\u2019Neal VM, Diamond JH, Borchelt DR. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neuropathol (Berl). 2016;131:103\u201314.","journal-title":"Acta Neuropathol (Berl)."},{"key":"820_CR253","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ana.23937","volume":"74","author":"J Brettschneider","year":"2013","unstructured":"Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis: ALS stages. Ann Neurol. 2013;74:20\u201338.","journal-title":"Ann Neurol."},{"key":"820_CR254","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(16)00737-6","volume":"388","author":"JR Burrell","year":"2016","unstructured":"Burrell JR, Halliday GM, Kril JJ, Ittner LM, G\u00f6tz J, Kiernan MC, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388:919\u201331.","journal-title":"Lancet"},{"key":"820_CR255","first-page":"CD008191","volume":"2","author":"DP Seitz","year":"2011","unstructured":"Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P. Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev. 2011;2:CD008191.","journal-title":"Cochrane Database Syst Rev."},{"key":"820_CR256","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1468-1331.2011.03501.x","volume":"19","author":"PM Andersen","year":"2012","unstructured":"Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS): revised report of an EFNS task force: EFNS Task Force on Management of ALS. Eur J Neurol. 2012;19:360\u201375.","journal-title":"Eur J Neurol."},{"key":"820_CR257","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1474-4422(12)70320-4","volume":"12","author":"AL Boxer","year":"2013","unstructured":"Boxer AL, Knopman DS, Kaufer DI, Grossman M, Onyike C, Graf-Radford N, et al. Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2013;12:149\u201356.","journal-title":"Lancet Neurol."},{"issue":"4","key":"820_CR258","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5664\/jcsm.2586","volume":"9","author":"HD Katzberg","year":"2013","unstructured":"Katzberg HD, Selegiman A, Guion L, Yuan N, Cho SC, Katz JS, et al. Effects of noninvasive ventilation on sleep outcomes in amyotrophic lateral sclerosis. J Clin Sleep Med. 2013;9(4):345\u201351.","journal-title":"J Clin Sleep Med."},{"key":"820_CR259","first-page":"CD009402","volume":"9","author":"SR Garrison","year":"2020","unstructured":"Garrison SR, Korownyk CS, Kolber MR, Allan GM, Musini VM, Sekhon RK, et al. Magnesium for skeletal muscle cramps. Cochrane Database Syst Rev. 2020;9:CD009402.","journal-title":"Cochrane Database Syst Rev."},{"key":"820_CR260","doi-asserted-by":"publisher","first-page":"35","DOI":"10.11138\/FNeur\/2017.32.1.035","volume":"32","author":"L Libonati","year":"2017","unstructured":"Libonati L, Onesti E, Gori MC, Ceccanti M, Cambieri C, Fabbri A, et al. Vitamin D in amyotrophic lateral sclerosis. Funct Neurol. 2017;32:35\u201340.","journal-title":"Funct Neurol."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-021-00820-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-021-00820-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-021-00820-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T15:46:14Z","timestamp":1699026374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-021-00820-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":260,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1007\/s40263-021-00820-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740118664.793586185","asserted-by":"object"}]},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"20 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Colin J. Mahoney is funded by a post-doctoral University of Sydney Fellowship. This study was conducted by ForeFront, a large collaborative research group dedicated to the study of neurodegenerative diseases and funded by the National Health and Medical Research Council of Australia Program Grant (1132524), Dementia Research Team Grant (#1095127) and Partnership Project (1153439). Matthew C. Kiernan was supported by a NHMRC Practitioner Fellowship (1156093). Orla Hardiman reports receiving grants from Science Foundation Ireland. No specific funding was provided for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Orla Hardiman reports personal fees from\u00a0Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Taylor & Francis, Cytokinetics and Wave Pharmaceuticals. Matthew C. Kiernan is the Editor-in-Chief\u00a0of the <i>Journal of Neurology, Neurosurgery and Psychiatry<\/i>. Colin J. Mahoney, Rebekah M. Ahmed, William Huynh, Sicong Tu, Jonathan D. Rohrer and Richard S. Bedlack have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"CJM and MCK conceived this article. CJM, RMA, WH and MCK determined the scope of article. CJM undertook the literature search and completed the initial draft paper. RMA, WH, ST, JDR, RSB and OH provided critical commentary and revised the final article. All authors reviewed and approved the final manuscript and agree to be accountable for the article content.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}